All
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Search
Notebook
Report an inappropriate content
Please select one of the options below.
Not Relevant
Offensive
Adult
Child Sexual Abuse
Top suggestions for Imfinzi NSCLC Resources
Immunotherapy
Durvalumab by
Imfinzi
Adenocarcinoma
Lung
Checkpoint
Key
Survival of Lung
Cancer
Radiation Therapy
for Bladder Cancer
Immunotherapy
Treatment
Immune Checkpoint
Inhibitors
Subcutaneous Cancer
Cell Injection
Rituximab Maintenance
Follicular Lymphoma
PD-1 Inhibitor
Mechanism
Tumor
Immunology
Keytruda
Lung
Progression After
Durvalumab
Cancer
Meds
New Lung Cancer
Treatments
Staging of Lung
Cancer
4 Stage Lung Cancer
Treatable
Nanogel for Cancer
Treatment
Living with Lung
Cancer
Immunotherapy and
Lung Cancer Review
Immunotherapy for Lung
Cancer Mesothelioma
Length
All
Short (less than 5 minutes)
Medium (5-20 minutes)
Long (more than 20 minutes)
Date
All
Past 24 hours
Past week
Past month
Past year
Resolution
All
Lower than 360p
360p or higher
480p or higher
720p or higher
1080p or higher
Source
All
Dailymotion
Vimeo
Metacafe
Hulu
VEVO
Myspace
MTV
CBS
Fox
CNN
MSN
Price
All
Free
Paid
Clear filters
SafeSearch:
Moderate
Strict
Moderate (default)
Off
Filter
Immunotherapy
Durvalumab by
Imfinzi
Adenocarcinoma
Lung
Checkpoint
Key
Survival of Lung
Cancer
Radiation Therapy
for Bladder Cancer
Immunotherapy
Treatment
Immune Checkpoint
Inhibitors
Subcutaneous Cancer
Cell Injection
Rituximab Maintenance
Follicular Lymphoma
PD-1 Inhibitor
Mechanism
Tumor
Immunology
Keytruda
Lung
Progression After
Durvalumab
Cancer
Meds
New Lung Cancer
Treatments
Staging of Lung
Cancer
4 Stage Lung Cancer
Treatable
Nanogel for Cancer
Treatment
Living with Lung
Cancer
Immunotherapy and
Lung Cancer Review
Immunotherapy for Lung
Cancer Mesothelioma
IMFINZI® (durvalumab)
Nov 14, 2018
imfinzi.com
Dr. Langer Discusses the Impact of Targeted Therapy in NSCLC
May 15, 2019
onclive.com
Durvalumab (Imfinzi) FDA Approved for Stage III NSCLC: Standard of C
…
10 views
Dec 15, 2019
vumedi.com
A Retrospective Look at ALK-Rearranged NSCLC Management
Feb 4, 2020
onclive.com
The Exciting Future of NSCLC Treatment
Nov 23, 2022
onclive.com
Dr. Graziano on Sequencing Targeted Therapy in NSCLC
Mar 28, 2019
onclive.com
Overcoming Resistance in EGFR NSCLC
201 views
Jul 3, 2023
vumedi.com
Immuno- and Chemotherapy Approach to R/R NSCLC
Feb 4, 2020
onclive.com
NSCLC: Consolidation Immunotherapy in Practice
Mar 13, 2018
onclive.com
Harnessing Immunotherapy-Based Strategies for Advanced NSCLC
100 views
Jun 14, 2022
vumedi.com
Novel Approaches in the Treatment of NSCLC
359 views
Sep 22, 2023
vumedi.com
Immunotherapy for Relapsed/Refractory NSCLC
Jul 13, 2017
onclive.com
IPI/NIVO in Metastatic NSCLC
Jun 28, 2018
onclive.com
AstraZeneca: Imfinzi Plus Chemotherapy Improved PCR In R
…
Jun 29, 2022
nasdaq.com
The Utility of Rapid Lung NGS for Biomarker Testing in NSCLC
2 months ago
onclive.com
AstraZeneca's Imfinzi gets FDA priority review for small cell lung
…
Nov 28, 2019
nasdaq.com
Immunotherapy for Relapsed or Refractory NSCLC
Sep 28, 2017
onclive.com
US regulator approves AstraZeneca's Imfinzi for small ce
…
2 months ago
proactiveinvestors.com.au
1:03
FDA Prioritizes AstraZeneca’s Imfinzi for Small Cell Lung Cance
…
5 months ago
Microsoft News
Revolution Daily
Clinical Pearls and Closing Thoughts on NSCLC Treatment La
…
Oct 10, 2023
onclive.com
Practical Considerations for Immunotherapy in Stage 3 NSCLC
Jan 30, 2018
onclive.com
Stage 3 NSCLC Highlights: 5-Year Overall Survival Updates From th
…
186 views
Jan 23, 2022
vumedi.com
NSCLC & Targeted Therapy: A Brief Overview and Update in the Metas
…
506 views
Dec 14, 2023
vumedi.com
Emerging Immunotherapies and Combinations for NSCLC
Jul 13, 2017
onclive.com
4:41
Metastatic NSCLC: Key Challenges in Molecular Testing and Treatme
…
Dec 11, 2023
onclive.com
Accurate Staging and Determining Resectability in NSCLC
8 months ago
reachmd.com
Dr. McKenzie on Navigating the Landscape of Biomarker Testing i
…
Oct 24, 2022
onclive.com
An Update on Lung Cancer Targeted Therapies: The Evolutio
…
266 views
5 months ago
vumedi.com
Advances in Immunotherapy for Unresectable Stage III NSCLC
8 months ago
reachmd.com
Checkpoint Inhibitor Combination Therapy for First-Line Advanced
…
Sep 13, 2021
reachmd.com
See more videos
More like this
Feedback
Feedback